EWTX vs PHAR
Edgewise Therapeutics, Inc. · Pharming Group N.V.
Relative return (rebased to 100)
Key stats
| Metric | EWTX | PHAR |
|---|---|---|
| Price | $39.75 | $12.01 |
| Market Cap | $4.28B | $8.43B |
| P/E | — | 2955.87 |
| P/B | 8.67 | 30.41 |
| P/S | — | 22.40 |
| ROE | -34.0% | 1.0% |
| Net Margin | — | 0.8% |
| Gross Margin | — | 87.9% |
| Revenue Growth | — | 26.6% |
| Dividend Yield | — | — |
| EPS | -$1.56 | $0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.